Hanyang rheumatic disease hospital to focus on intractable diseases
기사승인 2018.05.16 15:21:20
So Jae-hyeon sjh@docdocdoc.co.kr
- 1Pharma5 Korean biopharmaceuticals most active in P3 trials in 5 years
- 2Bio‘Pharmaceutical stocks to bottom out soon’
- 3Policy‘Law should protect Good Samaritan doctors’
- 4PharmaShire’s hereditary angioedema therapy gets insurance coverage
- 5HospitalMajor hospitals successfully contain Korea’s 1st MERS case in 3 years
- 6Policy81% of N. Korean defectors have tuberculosis
- 7Pharma‘Xgeva reduces risk of bone problems in solid tumor patients’
set_C1
